Lifevantage: Pay

Lifevantage paid CEO Michael Beindorff $233.0K in FY2026 (Dec). No other named executive of that year is on file.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Michael BeindorffInterim President and Chief Executive Officer
FY2026 (Dec)
1 year

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2026 (Dec).

  1. 1Lifevantage
  2. 2Grove CollaborativeNot disclosed
  3. 3Jamieson Wellness, Inc.Not disclosed
  4. 4Lifeway FoodsNot disclosed
  5. 5MedifastNot disclosed
  6. 6Natural Alternatives International, Inc.Not disclosed
  7. 7Nature’s Sunshine Products, Inc.Not disclosed
  8. 8Niagen BiosciencesNot disclosed
  9. 9Nu Skin EnterprisesNot disclosed
  10. 10Olaplex Holdings, Inc.Not disclosed
  11. 11PetMed ExpressNot disclosed
  12. 12Honest CompanyNot disclosed
  13. 13Usana Health SciencesNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.